日本ドライアイ治療薬市場規模シェア、競争環境、トレンド分析レポート:疾患タイプ別(蒸発性ドライアイ症候群、水分欠乏性ドライアイ症候群)、投与形態別(ジェル、目薬ソリューション、カプセルおよび錠剤、点眼薬、軟膏)、流通チャネル別(病院薬局、小売薬局、オンライン薬局): 2024-2032 年の機会分析と産業予測
レポートID : ROJP1024323 | 発行日 : 2024年10月 | フォーマット : : :
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Japan Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Evaporative Dry Eye Syndrome
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aqueous Dry Eye Syndrome
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Dosage Form
8.1 Gels
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Eye Solutions
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Capsules & Tablets
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Drops
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Ointments
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 Kanto Region
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Kinki Region
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Central/ Chubu Region
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Kyushu-Okinawa Region
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Tohoku Region
10.5.1 Market Trends
10.5.2 Market Forecast
10.6 Chugoku Region
10.6.1 Market Trends
10.6.2 Market Forecast
10.7 Hokkaido Region
10.7.1 Market Trends
10.7.2 Market Forecast
10.8 Shikoku Region
10.8.1 Market Trends
10.8.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16. Competitive Landscape
16.1. AbbVie GK
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Novartis Pharma K.K.
16.3. Santen Pharmaceutical Co., Ltd.
16.4. Janssen Pharmaceuticals K.K.
16.5. Senju Pharmaceutical Co., Ltd.
16.6. Taisho Pharmaceutical Co., Ltd
16.7. Otsuka Pharmaceutical Co., Ltd.
16.8. Sun Pharma Japan Limited
16.9. Asahi Kasei Pharma Corporation
16.10. Kyowa Pharmaceutical Industry Co., Ltd.
17. Strategic Recommendations
18. About Us & Disclaimer